August 17, 2016
Following the death of its Chairman and Chief Executive Officer Giovanni Recordati this week, the board of Recordati (Milan, Italy) appointed Alberto Recordati as Chairman of the Board of Directors and Andrea Recordati as Vice Chairman and Chief Executive Officer.
Andrea has been Chief Operating Officer since 2013, in charge of the group’s commercial and production activities. Alberto Recordati has been responsible for drug discovery and development activities since 2008 and for licensing-in activities since 2011.
Giovanni Recordati had been Chief Executive Officer of the company since 1990.
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based Products
April 10th 2025As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.